Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India
Launched by TERESA HOWARD · Aug 23, 2016
Trial Information
Current as of August 29, 2025
Unknown status
Keywords
ClinConnect Summary
This is a longitudinal prospective cohort study of injured patients being transported by ambulance to the major trauma centre study sites. In the pre-intervention phase, prospective data on patients will be collected on pre-hospital assessment, notification, in-hospital assessment, management and outcomes and recorded in a new tailored multi-hospital trauma registry. All injured patients arriving by ambulance and allocated to a red or yellow priority category will be eligible for inclusion. The intervention will be a pre-hospital notification application in the form of an Android program th...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: All injured patients arriving by ambulance and allocated to a red (1st) or yellow (2nd) priority category will be eligible for inclusion. Data will be collected prospectively by trained data collectors positioned in the trauma centres.
- Retrospective inclusion will be continued for all screened patients presenting to any of the included hospitals with injury (including near-drowning) as the primary diagnosis and with at least one of the following criteria:
- • 1. Admission to hospital
- • 2. Death after triage but before admission
- • 3. Dead on arrival
- Exclusion criteria: Patients meeting screening criteria will be subsequently excluded if they meet any of the following criteria:
- • 1. Dead at scene
- • 2. Alive at triage but not admitted to hospital (discharged alive)
- • 3. Isolated poisoning
- • 4. Isolated burns
- • 5. Single digit finger or toe amputations (unless of the thumb or great toe), only
About Teresa Howard
Teresa Howard is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, she leads initiatives that prioritize safety, efficacy, and ethical standards in clinical trials. Her expertise encompasses a wide range of therapeutic areas, and she collaborates with researchers, healthcare professionals, and regulatory bodies to ensure the successful design and execution of clinical studies. Through her leadership, Teresa Howard aims to contribute significantly to the development of new treatments and enhance the overall landscape of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ahmedabad, Gujarat, India
Delhi, , India
Delhi, , India
Mumbai, , India
Patients applied
Trial Officials
Mark C Fitzgerald, MBBS, MD
Principal Investigator
National Trauma Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials